Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 431


The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.

Elgart A, Zur AA, Mimrod D, Dror V, Bar-Ilan O, Korver T, Spiegelstein O.

Eur J Clin Pharmacol. 2019 Jan;75(1):41-49. doi: 10.1007/s00228-018-2549-7. Epub 2018 Sep 6.


Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa.

Vajapeyam S, Ecklund K, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, Rosen CJ, Gordon CM.

Bone. 2018 May;110:335-342. doi: 10.1016/j.bone.2018.02.021. Epub 2018 Feb 26.


Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.


Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill.

Engman J, Sundström Poromaa I, Moby L, Wikström J, Fredrikson M, Gingnell M.

Neuropsychopharmacology. 2018 Feb;43(3):555-563. doi: 10.1038/npp.2017.157. Epub 2017 Jun 25.


Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.

Ibáñez L, Del Río L, Díaz M, Sebastiani G, Pozo ÓJ, López-Bermejo A, de Zegher F.

J Adolesc Health. 2017 Oct;61(4):446-453. doi: 10.1016/j.jadohealth.2017.04.010. Epub 2017 Jul 14.


Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.

Priya K, Rajaram S, Goel N.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:141-146. doi: 10.1016/j.ejogrb.2016.10.026. Epub 2016 Nov 8.


Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial.

Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B, Johannesson M, Hirschberg AL.

J Clin Endocrinol Metab. 2016 Nov;101(11):4046-4053. Epub 2016 Aug 15.


A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.

Borgatta L, Buhling KJ, Rybowski S, Roth K, Rosen K.

Eur J Contracept Reprod Health Care. 2016 Oct;21(5):372-9. doi: 10.1080/13625187.2016.1212987. Epub 2016 Aug 5.


Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.

Contraception. 2017 Nov;96(5):322-329. doi: 10.1016/j.contraception.2016.06.022. Epub 2016 Jul 5.


Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.

Gersten J, Hsieh J, Weiss H, Ricciotti NA.

J Pediatr Adolesc Gynecol. 2016 Dec;29(6):635-642. doi: 10.1016/j.jpag.2016.05.012. Epub 2016 Jun 7.


Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.

Dahiya P, Dalal M, Yadav A, Dahiya K, Jain S, Silan V.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:147-51. doi: 10.1016/j.ejogrb.2016.05.009. Epub 2016 May 20.


Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.

Menon S, Riese R, Wang R, Alvey CW, Shi H, Petit W, Krishnaswami S.

Clin Pharmacol Drug Dev. 2016 Sep;5(5):336-42. doi: 10.1002/cpdd.270. Epub 2016 Jun 26.


Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.

Gan L, Jiang X, Mendonza A, Swan T, Reynolds C, Nguyen J, Pal P, Neelakantham S, Dahlke M, Langenickel T, Rajman I, Akahori M, Zhou W, Rebello S, Sunkara G.

Clin Pharmacol Drug Dev. 2016 Jan;5(1):27-39. doi: 10.1002/cpdd.181. Epub 2015 Nov 4.


Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical Studies.

Martin P, Gillen M, Ritter J, Mathews D, Brealey C, Surry D, Oliver S, Holmes V, Severin P, Elsby R.

Drugs R D. 2016 Mar;16(1):93-107. doi: 10.1007/s40268-015-0120-x.


Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.

Duijkers IJ, Klipping C, Zimmerman Y, Appels N, Jost M, Maillard C, Mawet M, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):476-89. doi: 10.3109/13625187.2015.1074675.


The effect of combined hormonal contraceptives use on brain reactivity during response inhibition.

Gingnell M, Bannbers E, Engman J, Frick A, Moby L, Wikström J, Sundström-Poromaa I.

Eur J Contracept Reprod Health Care. 2016;21(2):150-7. doi: 10.3109/13625187.2015.1077381. Epub 2015 Aug 20.


Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.

Mawet M, Maillard C, Klipping C, Zimmerman Y, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):463-75. doi: 10.3109/13625187.2015.1068934. Epub 2015 Jul 27.


Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.

Guiahi M, McBride M, Sheeder J, Teal S.

Obstet Gynecol. 2015 Sep;126(3):508-13. doi: 10.1097/AOG.0000000000000974.


Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers.

Xin X, Wu Y, Liu X, Sun C, Geng T, Ding L.

Drug Res (Stuttg). 2016 Feb;66(2):100-6. doi: 10.1055/s-0035-1554631. Epub 2015 Jun 2.


Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.

Sivasubramanian R, Chakraborty A, Rouzade-Dominguez ML, Neelakantham S, Jakab A, Mensinga T, Legangneux E, Woessner R, Ufer M.

Int J Clin Pharmacol Ther. 2015 Jul;53(7):550-6. doi: 10.5414/CP202321.


Supplemental Content

Loading ...
Support Center